No. |
DrugBank |
薬物名(臨床試験情報から抽出) |
KEGG DRUG * | KEGG GENES * |
KEGG PATHWAY |
指定難病告示番号 * |
1 | Baclofen | 5件: Aert, (r)-baclofen; Baclofen; Baclofen 20 mg; Baclofen ir; Rs-baclofen; | D00241 |
2件: GABBR1, GABBR2 |
7件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway |
5件: 2, 10, 13, 18, 149 |
2 | Botulinum toxin type A | 3件: Botulinum toxin type a; Botulinum toxin type a (nabota®) injection into the gastrocnemius muscle; Clostridium botulinum toxin type a; | D00783 |
1件: SNAP25 |
2件: Insulin secretion, Synaptic vesicle cycle |
13件: 2, 5, 6, 7, 13, 15, 17, 36, 51, 70, 113, 149, 226 |
3 | Brivaracetam | 3件: Brivaracetam; Brivaracetam 25 mg; Brivaracetam 50 mg; | D08879 |
1件: SV2A |
1件: ECM-receptor interaction |
2件: 149, 309 |
4 | Edonerpic | 1件: Edonerpic; | - |
- |
- |
1件: 149 |
5 | Isoxaflutole | - | - |
- |
- |
8件: 5, 6, 13, 18, 81, 113, 149, 299 |
6 | Lacosamide | 1件: Lacosamide; | D07299 |
2件: SCN3A, SCN9A |
1件: Taste transduction |
3件: 2, 46, 149 |
7 | Padsevonil | 1件: Padsevonil; | - |
- |
- |
1件: 149 |
8 | Sodium oxybate | 1件: Sodium oxybate; | D05866 |
- |
- |
3件: 6, 120, 149 |
9 | Triheptanoin | 4件: Triheptanoin; Triheptanoin 1g/kg/day; Triheptanoin oil; Ux007 (triheptanoin); | D11465 |
- |
- |
10件: 2, 8, 120, 149, 156, 248, 256, 257, 317, 324 |
10 | gamma-Hydroxybutyric acid | - | - |
- |
- |
3件: 6, 120, 149 |